Stimuli-Responsive Polypeptide Nanoparticles for Enhanced DNA Delivery.
cross-linked nanoparticles
gene delivery
pH and redox-responsive delivery systems
polypeptides
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
02 Dec 2022
02 Dec 2022
Historique:
received:
26
10
2022
revised:
27
11
2022
accepted:
28
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
The development of non-viral delivery systems for effective gene therapy is one of the current challenges in modern biomedicinal chemistry. In this paper, the synthesis of pH- and redox-responsive amphiphilic polypeptides for intracellular DNA delivery is reported and discussed. Two series of polypeptides consisting of L-lysine, L-phenylalanine, L-histidine, and L-cysteine as well as the same amino acids with L-glutamic acid were synthesized by a combination of copolymerization of N-carboxyanhydrides of α-amino acids and post-polymerization modification of the resulting copolymers. The presence of histidine provided pH-sensitive properties under weakly acidic conditions specific to endosomal pH. In turn, the presence of cysteine allowed for the formation of redox-responsive disulfide bonds, which stabilized the self-assembled nanoparticles in the extracellular environment but could degrade inside the cell. The formation of intraparticle disulfide bonds resulted in their compactization from 200-250 to 55-100 nm. Empty and pDNA-loaded cross-linked nanoparticles showed enhanced stability in various media compared to non-crosslinked nanoparticles. At the same time, the addition of glutathione promoted particle degradation and nucleic acid release. The delivery systems were able to retain their size and surface charge at polypeptide/pDNA ratios of 10 or higher. GFP expression in HEK 293 was induced by the delivery of pEGFP-N3 with the developed polypeptide nanoparticles. The maximal transfection efficacy (70%) was observed when the polypeptide/pDNA ratio was 100.
Identifiants
pubmed: 36500587
pii: molecules27238495
doi: 10.3390/molecules27238495
pmc: PMC9736633
pii:
doi:
Substances chimiques
Peptides
0
DNA
9007-49-2
Disulfides
0
Amino Acids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Russian Foundation for Basic Research
ID : 20-33-90181
Organisme : Russian Science Foundation
ID : 21-73-20104
Références
Pharmaceutics. 2020 Jan 02;12(1):
pubmed: 31906576
Nucleic Acids Res. 2001 Mar 15;29(6):1334-40
pubmed: 11239000
Biomacromolecules. 2009 Jan 12;10(1):119-27
pubmed: 19061333
Biophys Rev. 2018 Feb;10(1):69-86
pubmed: 29327101
Genome Med. 2017 Jun 27;9(1):60
pubmed: 28655327
Acc Chem Res. 2019 Jul 16;52(7):1750-1760
pubmed: 31243966
Mol Ther Methods Clin Dev. 2022 Jun 9;25:205-214
pubmed: 35308783
Polymers (Basel). 2020 May 05;12(5):
pubmed: 32380700
J Control Release. 2020 Jun 10;322:95-107
pubmed: 32194172
J Control Release. 2015 Jul 28;210:115-24
pubmed: 25980622
Bioorg Med Chem Lett. 2016 Dec 15;26(24):5911-5915
pubmed: 27836397
Cancer Res. 2002 Jan 1;62(1):307-12
pubmed: 11782393
Adv Sci (Weinh). 2021 May 14;8(13):2100328
pubmed: 34258165
J Gene Med. 2005 Jul;7(7):977-86
pubmed: 15772938
Appl Microbiol Biotechnol. 2003 Jul;62(1):27-34
pubmed: 12719940
J Am Chem Soc. 2004 Mar 3;126(8):2355-61
pubmed: 14982439
J Biol Chem. 2000 Apr 7;275(14):9970-7
pubmed: 10744672
ACS Nano. 2012 Nov 27;6(11):9900-10
pubmed: 23062017
J Gene Med. 2001 Jul-Aug;3(4):362-72
pubmed: 11529666
Int J Biol Macromol. 2021 Sep 1;186:864-872
pubmed: 34274401
Adv Drug Deliv Rev. 2001 Dec 3;53(1):75-94
pubmed: 11733118
Biochim Biophys Acta Biomembr. 2018 Jun;1860(6):1394-1402
pubmed: 29621495
Macromol Biosci. 2022 May;22(5):e2100445
pubmed: 35182032
Bioorg Khim. 2009 Jul-Aug;35(4):483-92
pubmed: 19928050
Int J Pharm. 2000 Dec 4;210(1-2):97-107
pubmed: 11163991
J Sci Med Sport. 2019 Sep;22(9):981-986
pubmed: 31129082
Adv Drug Deliv Rev. 2021 Nov;178:113834
pubmed: 34492233
J Biomed Mater Res. 1996 Jan;30(1):53-65
pubmed: 8788106
Front Pharmacol. 2014 Jul 01;5:151
pubmed: 25024695
J Control Release. 2021 Feb 10;330:753-764
pubmed: 33422500
J Control Release. 2022 Feb;342:241-279
pubmed: 35016918
J Control Release. 2021 Oct 10;338:537-547
pubmed: 34481924
Trends Pharmacol Sci. 2019 Oct;40(10):747-762
pubmed: 31493931